Earnings History Data for Adverum Biotechnologies (ADVM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Adverum Biotechnologies

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum?s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-08-2024 AH ADVM Adverum Biotechnologies 144.00 -0.89 -1.27 0.00 Adverum Biotechnologies GAAP EPS of -$0.89 beats by $0.58
[8/12/2024 4:47 PM]
6.72 0.23 
(3.54%)
6.62 0.13 
(2.00%)
6.38 - 29.70 130,071 220,000 2,612
18-03-2024 AH ADVM Adverum Biotechnologies 358.00 -0.23 -0.28 0.00 Adverum Biotechnologies GAAP EPS of -$0.23 beats by $0.11
[3/18/2024 4:35 PM]
1.63 -0.14 
(-7.91%)
1.68 -0.09 
(-5.08%)
0.68 - 2.97 3,265,218 2,000,000 11,032
30-03-2023 PM ADVM Adverum Biotechnologies 80.00 -0.33 -0.32 0.00 Adverum Biotechnologies GAAP EPS of -$0.33 beats by $0.03
[3/31/2023 12:36 AM]
0.7199 0.0 
(-0.01%)
0.77 0.05 
(6.94%)
0.53 - 1.82 90,847 720,000 2,066
29-03-2022 AH 4:05 PM ET
(Mar 29)
ADVM Adverum Biotechnologies, Inc. 137.41 -0.35 -0.42 -0.39 Adverum Biotechnologies GAAP EPS of -$0.35 misses by $0.01
[3/29/2022 4:49 PM]
1.34 -0.04 
(-3.24%)
1.39 0.0 
(0.00%)
1.21 - 10.85 526,035 2,010,000 1,400
05-08-2021 AH 4:00 PM ET
(Aug 5)
ADVM Adverum Biotechnologies, Inc. 231.00 -0.45 -0.37 0.00 Adverum Biotechnologies EPS misses by $0.07
[8/5/2021 5:25 PM]
2.48 0.07 
(2.90%)
2.36 -0.05 
(-2.07%)
2.23 - 19.25 1,908,386 3,170,000 25,225
01-03-2021 AH 4:00 PM ET
(Mar 1)
ADVM Adverum Biotechnologies, Inc. 1,250 -0.39 -0.32 -0.29 Adverum Biotechnologies EPS misses by $0.06
[3/1/2021 4:06 PM]
12.29 -1.03 
(-7.73%)
13.25 -0.07 
(-0.53%)
7.36 - 26.98 547,251 749,925 1,028
05-11-2020 AH ADVM Adverum Biotechnologies, Inc. 1,180 -0.31 -0.35 -0.25 Adverum Biotechnologies EPS beats by $0.04, beats on revenue
[11/5/2020 5:18 PM]
12.05 -0.13 
(-1.07%)
12.18 0.0 
(0.00%)
7.15 - 26.98 497,691 837,892 100
10-08-2020 AH 4:00 PM ET
(Aug 10)
ADVM Adverum Biotechnologies, Inc. 1,430 -0.36 -0.30 -0.23 Adverum Biotechnologies EPS misses by $0.06, beats on revenue
[8/10/2020 4:09 PM]
16.75 -1.95 
(-10.43%)
19.00 0.30 
(1.60%)
4.96 - 26.98 991,114 702,921 2,028
28-05-2020 AH 4:00 PM ET
(May 28)
ADVM Adverum Biotechnologies, Inc. 1,640 -0.31 -0.27 -0.23 Adverum Biotechnologies EPS misses by $0.04
[5/28/2020 4:11 PM]
17.97 -2.35 
(-11.56%)
19.88 -0.44 
(-2.17%)
4.96 - 23.79 868,899 934,250 379